ClinVar Miner

Submissions for variant NM_001844.5(COL2A1):c.1520G>A (p.Gly507Glu)

dbSNP: rs868417981
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000781310 SCV000919236 likely pathogenic Achondrogenesis type II 2018-07-05 criteria provided, single submitter clinical testing Variant summary: COL2A1 c.1520G>A (p.Gly507Glu) results in a non-conservative amino acid change located in the Gly-X-Y motif of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 22098 control chromosomes. To our knowledge, no occurrence of c.1520G>A in individuals affected with Achondrogenesis, type II and no experimental evidence demonstrating its impact on protein function have been reported. Alteration of the same codon, c.1519G>A (p.Gly507Arg) has been reported in 1 French patient presented with clinical features suggestive of SEMD Strudwick type (Barat-Houari, 2016). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.